-
The Senior Manager FP&A Bio Development, Manufacturing & Supply plays a key role in driving financial planning, forecasting, reporting, performance analysis and management insight across the Bio Development, Manufacturing & Supply organization. The role enables transparency on financial performance, productivity, cost development, investment priorities and key value drivers, supporting informed decision-making for Finance and business leadership. Acting as a trusted partner to the Head FP&A Bio Development, Manufacturing & Supply, the broader Bio Finance leadership team, Corporate FP&A and cross-functional stakeholders, the incumbent ensures high-quality, timely and consistent financial outputs while continuously improving FP&A processes, tools and analytics capabilities.
Your Key Responsibilities:
Your responsibilities include, but not limited to:
Coordinate Bio Development, Manufacturing & Supply reporting, forecasting, budgeting, and planning cycles, ensuring alignment with business priorities, financial targets, and corporate timelines.
Deliveraccurate,timely, and insightful financial reporting with clear explanations of performance drivers, risks, opportunities, and recommended actions.
Drive continuous improvement of planning, forecasting, reporting processes, tools, and analytics capabilities to enhance efficiency, reliability, and business insights.
Act as a trusted FP&A business partner, translating operational developments into financial implications and decision-ready recommendations for stakeholders.
Prepare high-quality management analyses, financial narratives, presentations, dashboards, and standardized reporting packages, with a strong focus on visualization and business storytelling.
Monitor and analyze key financial and operational KPIs, including Core EBIT, period costs, conversion costs, COGS, productivity,CapEx, cash flow, inventory, FTE development, and overall business performance.
Manage central team budgets, support FP&A, productivity, automation, data quality, governance, and process improvement initiatives, while delivering ad-hoc analyses and contributing to team collaboration and knowledge sharing.
Partner closely with Corporate FP&A, Bio Finance, Technical Platforms, Development, Manufacturing, Supply, and Commercial Finance stakeholders to ensure consistency, transparency, and alignment.
Whatyou’llbring to the role:
Essential Requirements:
University degreein Economics, Business Administration, Engineering, or a relatedfield; Master DegreeMBA is desirable
Fluent Englishrequired;additionallocal language skills are an advantage.
5-8 years of progressive experiencein FP&A, performance management, financial reporting, controlling, or finance business partnering, ideally within pharmaceuticals, biosimilars, manufacturing, supply, or another complex global environment.
Strong analytical and conceptual thinking skills, with the ability to connect operational drivers, financial results, and business priorities.
Solid project management capabilities, able to manage multipleprioritiesand deliver results during planning, forecasting, and reporting cycles.
In-depth knowledge in businesssystemsas SAP,Alterixand enabling functions as SHAPE, Data Warehouse, IFP plus excellent Excel and PowerPoint skills
Advanced Excel and PowerPoint skills; experience with dashboards, data visualization, and automation toolsisconsidered an advantage.
Strong financial and business acumen, combined with attention to detail, a continuous improvement mindset, high integrity and accountability, resilience, cultural sensitivity, and the ability to build trusted partnerships across functions and geographies.
Monthly pension contribution matching your individual contribution up to 3% of your gross monthly base salary
Risk Life Insurance
5-week holiday per year (1 week above the Labor Law requirement)
Cafeteria employee benefit program – choice of benefits from Benefit Plus CZ in the amount of 12,000 CZK per year
Meal vouchers in amount of 120 CZK for each working day (full tax covered by company)
Multisport Card
Premium Health Care Program
Car allowance
Why Sandoz?
Sandoz is the global leader in Biosimilar and Generic medicines, a segment of the healthcare industry that delivers 80% of the world’s medicines at 30% of the cost, touching the lives of more than 1 billion people across 100+ countries! While we are proud of our achievements, we have an ambition to do more so that everyone can achieve the basic human right of good health.
With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help even more people gain access to low-cost, high-quality medicines, sustainably.
Our momentum is powered by an open, collaborative culture driven by our talented and ambitious colleagues, who, in return for applying their skills, experience an agile and collegiate environment with impactful careers, where diversity of thought is welcomed and where personal growth is supported!
Join us, help us make healthcare fairer and faster.
We are committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
#Sandoz
Skills Desired
Ability To Influence Key Stakeholders, AI Driven, Building Effective Teams, Capital Allocation, Critical Thinking, Data Cleansing / Normalization, Data Visualization, Financial And Management Reporting, Giving And Receiving Feedback, Insight Generation, Interpersonal Savvy, Managing Ambiguity, Market Understanding, Planning & Analysis, Pmi (Post-Merger Integration), Process Optimization, Rapid Problem Solving, Understanding Value Drivers

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc